Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1777 to 1826 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
889\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8393.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03984\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5903.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6506.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10217\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
890\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to trna synthetase class ii. [source:refseq;acc:nm\_152268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7925.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8241.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03981\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tryptophan 2,3-dioxygenase (ec 1.13.11.11) (tryptophan pyrrolase) (tryptophanase) (tryptophan oxygenase) (tryptamin 2,3-dioxygenase) (trpo). [source:swissprot;acc:p48775]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5350.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5896.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10203\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
891\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lymphoid enhancer binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha). [source:swissprot;acc:q9uju2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5385.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5933.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8357.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8689.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0398\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
892\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic protein nck1 (nck adaptor protein 1) (sh2/sh3 adaptor protein nck-alpha). [source:swissprot;acc:p16333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6784.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7475.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10182\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8119.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8442.71\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0398\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
893\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase delta subunit 2 (ec 2.7.7.7). [source:swissprot;acc:p49005]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8234.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8561.85\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6603.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7274.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10171\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
894\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase delta catalytic subunit (ec 2.7.7.7) (dna polymerase delta subunit p125). [source:swissprot;acc:p28340]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8234.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8561.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0398\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
parafibromin. [source:refseq;acc:nm\_024529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4331.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4771.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1016\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
895\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
excision repair protein ercc-6 (cockayne syndrome protein csb). [source:swissprot;acc:q03468]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7619.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7922.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03979\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10247.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1016\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
896\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
short-chain dehydrogenase/reductase 9; 17-beta hydroxysteroid dehydrogenase. [source:refseq;acc:nm\_178135]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8233.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8561.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03977\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle receptor alpha subunit (sr-alpha) (docking protein alpha) (dp-alpha). [source:swissprot;acc:p08240]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5208.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5737.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10155\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
897\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
anchor attachment protein 1; glycophosphatidylinositol anchor attachment 1; anchor attachment protein 1 (gaa1p, yeast) homolog. [source:refseq;acc:nm\_003801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8111.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8434.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03974\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 2 (hd2). [source:swissprot;acc:q92769]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5929.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6531.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10153\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
898\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
multiple coagulation factor deficiency 2; neural stem cell derived neuronal survival protein; multiple coagulation factor deficiency protein 2. [source:refseq;acc:nm\_139279]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5929.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6531.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10152\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
multiple inositol polyphosphate histidine phosphatase, 1; multiple inositol polyphosphate phosphatase 2; multiple inositol polyphosphate phosphatase 1. [source:refseq;acc:nm\_004897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8111.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8434.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03974\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
899\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5929.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6531.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10152\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
short-chain dehydrogenase/reductase 1. [source:refseq;acc:nm\_004753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8232.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8559.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03973\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
900\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cg9578-like; yeast ypr037w and worm c02c2.6 predicted proteins-like. [source:refseq;acc:nm\_152902]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4713.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4279.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10152\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.5 kda polypeptide (ec 2.7.7.6) (rpb9) (rpb14.5). [source:swissprot;acc:p36954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7782.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8091.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03969\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
901\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 1 (hd1). [source:swissprot;acc:q13547]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5929.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6531.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10151\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nad-dependent malic enzyme, mitochondrial precursor (ec 1.1.1.38) (nad-me) (malic enzyme 2). [source:swissprot;acc:p23368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8286.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8615.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03969\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
902\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10246.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11285.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10147\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
preimplantation protein 3; likely ortholog of preimplantation protein 3. [source:refseq;acc:nm\_015387]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7793.77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8102.84\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03966\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
903\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 11 precursor (er-associated dnaj protein 3) (erj3) (er-associated hsp40 co-chaperone) (hdj9) (pwp1- interacting protein 4). [source:swissprot;acc:q9ubs4]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
red cell acid phosphatase 1, isozyme f (ec 3.1.3.2) (acp1) (low molecular weight phosphotyrosine protein phosphatase) (ec 3.1.3.48) (adipocyte acid phosphatase, isozyme alpha). [source:swissprot;acc:p24666]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4986.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5492.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10146\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
904\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6167.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6785.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10031\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l44. [source:refseq;acc:nm\_022915]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7249.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7536.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03965\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
905\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8037.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03962\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err1 (estrogen-related receptor, alpha) (err-alpha) (estrogen receptor-like 1). [source:swissprot;acc:p11474]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10230.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11256.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1003\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
906\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic protein nck1 (nck adaptor protein 1) (sh2/sh3 adaptor protein nck-alpha). [source:swissprot;acc:p16333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8439.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03961\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6165.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6783.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10023\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
907\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba305p22.3 (breast carcinoma amplified sequence 4). [source:sptrembl;acc:q8ndy6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11852.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10773.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10019\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8269.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8597.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03961\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
908\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11848.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10770.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7589.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7890.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03958\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
909\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5995.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6595.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10005\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8334.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8664.4\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03955\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
910\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8038.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.55\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6522.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7175.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09999\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
911\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8377.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8708.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03951\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 5 (c-myc binding protein mm-1) (myc modulator 1). [source:swissprot;acc:q99471]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5480.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09996\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
912\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8251.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8577.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5480.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09996\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
913\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadp-dependent malic enzyme, mitochondrial precursor (ec 1.1.1.40) (nadp-me) (malic enzyme 3). [source:swissprot;acc:q16798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8275.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8602.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03941\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 2 (wbp-2). [source:swissprot;acc:q969t9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6342.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09943\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/